Astrana Health Enters Definitive Agreement To Acquire Collaborative Health Systems From Centene Corporation
Expands Payer-Agnostic Care Delivery Capabilities Serving Over 129,000 Beneficiaries Across 17 States
Expands Payer-Agnostic Care Delivery Capabilities Serving Over 129,000 Beneficiaries Across 17 States
Company | Date | Price Target | Rating | Analyst |
---|---|---|---|---|
7/24/2024 | $83.00 → $69.00 | Buy → Hold | Jefferies | |
7/11/2024 | $44.00 → $50.00 | Hold → Buy | Truist | |
5/30/2024 | $83.00 | Neutral | Robert W. Baird | |
5/30/2024 | $54.00 | Outperform | Robert W. Baird | |
3/21/2024 | $92.00 → $85.00 | Overweight → Equal-Weight | Stephens | |
3/6/2024 | $101.00 | Overweight | Barclays | |
1/2/2024 | $82.00 → $90.00 | Equal Weight → Overweight | Wells Fargo | |
8/30/2023 | $94.00 → $73.00 | Overweight → Equal-Weight | Morgan Stanley |
4 - Astrana Health, Inc. (0001083446) (Issuer)
4 - Astrana Health, Inc. (0001083446) (Issuer)
4 - Astrana Health, Inc. (0001083446) (Issuer)
Jefferies downgraded Centene from Buy to Hold and set a new price target of $69.00 from $83.00 previously
Truist upgraded Astrana Health from Hold to Buy and set a new price target of $50.00 from $44.00 previously
Robert W. Baird initiated coverage of Centene with a rating of Neutral and set a new price target of $83.00
SC 13G/A - CENTENE CORP (0001071739) (Subject)
SC 13G/A - CENTENE CORP (0001071739) (Subject)
SC 13G/A - CENTENE CORP (0001071739) (Subject)
Company to Host Conference Call on Wednesday, August 7, 2024, at 2:30 p.m. PT/5:30 p.m. ET ALHAMBRA, Calif., Aug. 7, 2024 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced its consolidated financial results for the second quarter ended June 30, 2024. "We believe our strong second quarter results and entry into new states refle
-- Diluted EPS of $2.16; Adjusted Diluted EPS of $2.42 ---- Reaffirms 2024 Adjusted Diluted EPS Guidance Floor of Greater Than $6.80 -- Adjusted diluted EPS of $2.42, up 15% from $2.10 in the second quarter of 2023.Premium and service revenues of $36.0 billion in the second quarter of 2024.Membership increase of 34% in Marketplace, compared to the second quarter of 2023.ST. LOUIS, July 26, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company") announced today its financial results for the second quarter ended June 30, 2024. In summary, the 2024 second quarter results were as follows: Total revenues (in millions) $ 39,836 Premium and service revenues (in millions) $
ALHAMBRA, Calif., July 23, 2024 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the second quarter ended June 30, 2024, after the close of the stock market on Wednesday, August 7, 2024. The Company will discuss those results on a conference call at 2:30 p.m. PT/5:30 p.m. ET that same day.
Expands Payer-Agnostic Care Delivery Capabilities Serving Over 129,000 Beneficiaries Across 17 States
Centene (NYSE:CNC) has outperformed the market over the past 20 years by 5.77% on an annualized basis producing an average annual return of 14.03%. Currently, Centene has a market capitalization of $34.60 billion. Buying $1000 In CNC: If an investor had bought $1000 of CNC stock 20 years ago, it would be worth $13,449.23 today based on a price of $64.84 for CNC at the time of writing. Centene's Performance Over Last 20 Years Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time. This article was generated by Benzinga's automated content engine and reviewed
TD Cowen analyst Gary Taylor maintains Centene (NYSE:CNC) with a Buy and lowers the price target from $91 to $80.
8-K - CENTENE CORP (0001071739) (Filer)
8-K - Astrana Health, Inc. (0001083446) (Filer)
8-K - CENTENE CORP (0001071739) (Filer)
ST. LOUIS, Aug. 15, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC) ("the Company") announced today that it has appointed Thomas R. Greco to the Centene Board of Directors, effective Aug. 9, 2024. Mr. Greco's term will run through the Company's 2025 annual meeting of stockholders. The appointment of Mr. Greco expands Centene's Board of Directors to 11 members. Mr. Greco is a seasoned operator and executive who brings more than four decades of public company leadership and expertise to Centene. Over the course of his career, he has implemented growth strategies and fostered
TAMPA, Fla., July 31, 2024 /PRNewswire/ -- Big Brothers Big Sisters of America (BBBSA), the nation's preeminent one-to-one youth mentoring organization, today announced the election of its newest Board member, Centene Corporation [Centene] (NYSE:CNC) Executive Vice President (EVP) of External Affairs, Jonathan Dinesman. Centene, a leading healthcare enterprise focused on transforming the health of the communities it serves, has been a long-time partner of BBBSA. Dinesman oversees Federal and State Government Relations; Centene's political action committee; Public Policy; Strat
Current Wellcare President & CEO, Richard Fisher, will join the Operations leadership team under Centene Chief Operating Officer Susan Smith, bringing additional Medicare expertise into Centene's core services operations ST. LOUIS, Jan. 22, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, today announced two appointments. Michael A. Carson joins Centene as President and Chief Executive Officer (CEO) of its Medicare business, Wellcare. Mr. Carson will be responsible for Medicare business performance, strategy and growth and will report to Centene President Ken Fasola. Carson succeeds Richard Fisher, who has
Health Net Assisting Members During State of Emergency SACRAMENTO, Calif., Sept. 12, 2024 /PRNewswire/ -- In response to Gov. Gavin Newsom's declared state of emergency in Los Angeles, Orange, Riverside and San Bernardino counties, Health Net, one of California's most experienced Medi-Cal managed care health plans and company of Centene Corporation (NYSE:CNC), is providing special assistance to assist members affected by the Bridge and Airport fires. Health Net is committed to ensuring its members have uninterrupted access to essential prescription medications, critical Health Net information and healthcare services.
The extra benefits are in addition to regular Medicaid and CHIP coverage, helping support low-income individuals and families across the state. AUSTIN, Texas, Sept. 12, 2024 /PRNewswire/ -- Superior HealthPlan ("Superior"), a leading managed care organization in Texas and a company of Centene Corporation (NYSE:CNC), announced today it invested $43.3 million in extra Medicaid and Children's Health Insurance Program (CHIP) benefits from 2019 through 2023. Known as Value-added Services, the extra benefits help provide additional support for low-income families and individuals across all 254 Texas counties.
Recognition Marks Third Consecutive Year of Centene's Annual Ranking ST. LOUIS, Sept. 12, 2024 /PRNewswire/ -- Centene Corporation (NYSE:CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that it has been recognized by Fortune magazine as one of the Best Workplaces in Health Care 2024™ in the Large Company category, for the third consecutive year. "Delivering the best care for our members requires going above and beyond for each other in the workplace," said Centene Chief Executive Officer Sarah M. London. "This recognition